Overweight and obesity are risks factors of severe illness in patients with COVID-19
Wang J, Zhu L, Liu L, Zhao XA, Zhang Z, Xue L, Yan X, Huang S, Li Y, Cheng J, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Shao H, Sang D, Zhao H, Guan X, Chen X, Chen Y, Issa R, Wei J, Huang R, Zhu C, Wu C.
Home medical nutrition during SARS-CoV-2 pandemic - A position paper
Matras P, Klek S, Folwarski M, Zmarzly A, Bartoszewska L, Cebulski W, Jakubczyk M, Kamocki Z, Klepczyk K, Kunecki M, Lawi≈Ñski M, Majewska K, Matczuk M, Matysiak-Lusnia K, Sadowski M, Sobocki J, Sumlet M, Szafranski W, Szczepanek K, Urbanowicz K, Zoubek-Wojcik A.
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre
Rottoli M, Bernante P, Belvedere A, Balsamo F, Garelli S, Giannella M, Cascavilla A, Tedeschi S, Ianniruberto S, Rosselli Del Turco E, Tonetti T, Ranieri VM, Poggioli G, Manzoli L, Pagotto U, Viale P, Bartoletti M.
Obesity and COVID-19 in New York City: A Retrospective Cohort Study
Goyal P, Ringel JB, Rajan M, Choi JJ, Pinheiro LC, Li HA, Wehmeyer GT, Alshak MN, Jabri A, Schenck EJ, Chen R, Satlin MJ, Campion TR Jr, Nahid M, Plataki M, Hoffman KL, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM.
The recommendations of the Brazilian College of Surgeons and the Brazilian Bariatric and Metabolic Surgery Societies on the return of bariatric and metabolic operations in geographic regions of the country where the procedures have been allowed by local policies, in the period of COVID-19 pandem
Bariatric surgery and the COVID-19 pandemic: SICOB recommendations on how to perform surgery during the outbreak and when to resume the activities in phase 2 of lockdown
Navarra G, Komaei I, Curr√≤ G, Angrisani L, Bellini R, Cerbone MR, Di Lorenzo N, De Luca M, Foletto M, Gentileschi P, Musella M, Nannipieri M, Piazza L, Olmi S, Pilone V, Raffaelli M, Sarro G, Vitiello A, Zappa MA, Foschi D.
Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S, Morita H, Altunbulakli C, Reiger M, Neumann AU, Lunjani N, Traidl-Hoffmann C, Nadeau K, O'Mahony L, Akdis CA, Sokolowska M.
Prevalence of obesity among adult inpatients with COVID-19 in France
Caussy C, Pattou F, Wallet F, Simon C, Chalopin S, Telliam C, Mathieu D, Subtil F, Frobert E, Alligier M, Delaunay D, Vanhems P, Laville M, Jourdain M, Disse E; COVID Outcomes HCL Consortium and Lille COVID‚ÄìObesity Study Group.